Abstract
Efficacy of Idelalisib and Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Treated Outside of Clinical Trial. a Report of the Gimema Group
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have